Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Search results

1-10 results from 690 for query «lupin»

17 November, 2017 2:39 PM Yes Bank, IndusInd to join India's BSE Sensex index; Lupin, Cipla dropped

Drugmakers Lupin Ltd and Cipla Ltd will make way for the two banks, according to a statement from Asia Index Pvt Ltd.  New Delhi: Indian private sector lenders Yes Bank Ltd and IndusInd Bank Ltd will join the BSE stock exchange`s 30-member Sensex index, effective Dec. 18, the index provider said on Friday. Drugmakers Lupin Ltd and Cipla Ltd will make way for the two banks 21

14 November, 2017 3:58 AM Market Live: Sensex tests 33,000 in opening, Nifty trades flat; Bharti Infra dips

Equity benchmarks opened flat on Tuesday after sharp correction seen in previous session. Investors focussed on corporate earnings. The 30-share BSE Sensex was down 14.55 points at 33,019.01 and the 50-share NSE Nifty fell 3 points to 10,222. Sun Pharma, HCL Technologies, Bharti Airtel, M&M, Lupin, Yes Bank, Kotak Mahindra Bank and Eicher Motors were early 40

7 November, 2017 4:38 PM Lupin gets USFDA warning

Drug firm Lupin said on Tuesday it had received a warning letter from the U.S. health regulator for its manufacturing facilities in Goa and Pithampur, Indore. “The company has received a warning letter issued by the United States Food and Drug Administration (USFDA) on November 6, 2017, for our formulation manufacturing facilities at Goa and Indore (Pithampur 29

2 November, 2017 8:18 AM Market Live: Nifty dips below 10,450; PSU banks, FMCG, metals stocks under pressure

2:05 pm Earnings: Borosil Glass share price rallied 8 percent as profit in July-September quarter increased 25 percent year-on-year to Rs 13.5 crore. Revenue grew by 17.7 percent to Rs 79.4 crore while operating profit climbed 77.1 percent to Rs 12.8 crore and margin expanded 540 basis points to 16.1 percent in Q2 YoY. 1:55 pm Buzzing: Orient 43

2 November, 2017 6:12 AM Sensex mirrors Asian gains, goes up after Fed holds rates

Mumbai: Stock markets rose on Thursday, in line with upbeat Asian shares, following an optimistic appraisal of economic conditions by the US Federal Reserve. The US central bank left interest rates unchanged at the end of its two-day policy meet, but remains on path for a possible December hike as it cited "solid rate" of growth. This lifted Asian markets 35

25 October, 2017 2:54 AM Stocks in the news: Infosys, SBI, HCL Tech, HUL, Kotak Bank, L&T, Idea Cellular, RCom

Infosys | SBI | PNB | Hindustan Unilever | Kotak Mahindra Bank | HCL Technologies | Bank of Baroda | Larsen & Toubro | Idea Cellular | Bank of India | Union Bank of India | Lupin | Reliance Communications | ICICI Prudential Life | ABB India | Ambuja Cements and Saregama India are stocks, which are in the news today. Cabinet Announces `2.11 Lk Cr Capitalisation 28

19 October, 2017 3:07 PM Muhurat Trading: Global cues drag Sensex 194 pts, Nifty Bank slips 304 pts on Day 1 of Samvat 2074

September quarter earnings will be closely watched from hereon, especially banks after sharp rise in Axis Bank's slippages, said experts who remain bullish on the market with long term perspective. The market started off Samvat 2074 on a negative note Thursday, with the Sensex falling 265 points intraday on selling pressure in banks. Weak global cues also dented 42

19 October, 2017 2:07 PM Muhurat Trading Closing bell: Sensex falls 194 pts, Nifty ends below 10,150; banks drag

7:30 pm Market Closing:Â Equity benchmarks closed the first day of Samvat 2074 on a weak note, dragged by banks stocks. Weak global cues also caused selling pressure in Indian equities. The 30-share BSE Sensex was down 194.39 points at 32,389.96 and the 50-share NSE Nifty fell 64.40 points to 10,146.50. All sectoral indices closed in red. Nifty Bank index 43

11 October, 2017 6:25 AM Lupin's US arm takes over Symbiomix Therapeutics

Drug major Lupin's US subsidiary has acquired Symbiomix Therapeutics for a total cash consideration of USD 150 million (nearly Rs 980 crore). Lupin had entered into an arrangement to acquire the company earlier this year. The acquisition has been made for a cash consideration of USD 150 million, including USD 50 million upfront payment and other time-based 30

10 October, 2017 12:53 PM Lupin launches pain relieving tablets in US

Drug firm Lupin today said it has launched its pain relieving Hydrocodone Bitartrate and Acetaminophen tablets in the American market. The company has launched Hydrocodone Bitartrate and Acetaminophen tablets USP in the strengths of 5mg/325 mg, 7.5 mg/325 mg and 10mg/325 mg after receiving approval from the US Food and Drug Administration (USFDA), Lupin 36